We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Long-Acting Peptide Therapy for Heart Failure To Be Developed by AL-Protein and Bioscience

Product News   Oct 16, 2020

 
Long-Acting Peptide Therapy for Heart Failure To Be Developed by AL-Protein and Bioscience

Credit: Joshua Coleman/ Unsplash

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Researchers Tackle the Surface Transmission of COVID-19 in New Partnership

Product News

A project to develop surface treatments that can provide long-lasting protection against the COVID-19 virus has been launched at the University of Birmingham.

READ MORE

Heidelberg Pharma Contracts ProBioGen for Cell Line Development and Manufacturing Services

Product News

Berlin, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, & Heidelberg Pharma AG, Ladenburg, Germany, today announced that Heidelberg Pharma has signed a Master Service Agreement for the antibodies used in two of their pipeline Antibody Targeted Amanitin Conjugate (ATAC) molecules.

READ MORE

Hydrophilic Vyon® Plastics Demonstrate High Performance for Drug Discovery Applications

Product News

Porvair Sciences reports on testing that demonstrates how its hydrophilic Vyon® porous plastics exhibit outstanding performance in drug discovery applications due to the high hydrophilic void volume conversion of the materials’ pore structure after a special treatment process.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE